Company News in the Life Science Industry

»

Reset 

Avectas and UC Davis Collaborate on Cell Engineering Technology

Collaboration will advance Avectas' cell engineering technology leveraging UC Davis' world-class cell membrane characterisation expertise

Read more ››
By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  Avectas

Novo Ventures Leads US$55M Series B Investment in NodThera

- Leading global life sciences venture investors

Read more ››
By: PR Newswire Association LLC. - 03 Jun 2020

Lip Augmentation Market Size Worth $4.4 Billion by 2027 | CAGR: 9.5%: Grand View Research, Inc.

SAN FRANCISCO, June 3, 2020 /PRNewswire/ -- The global lip... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Cell Expansion Market Worth $39.7 Billion by 2027 l CAGR 9.4%: Grand View Research, Inc.

SAN FRANCISCO, June 3, 2020 /PRNewswire/ --The global cell expansion... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Norwegian EXACT Therapeutics Appoints Rafiq Hasan as CEO

OSLO, Norway, June 3, 2020 /CNW/ -- EXACT THERAPEUTICS AS, a clinical stage precision medicine company utilizing Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announced it has appointed Dr Rafiq Hasan as CEO. He joins as the GE Healthcare spin-out, formerly... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

American CBD Giant PureKana Announces Release of Long-Awaited AM/PM CBD Capsules

NEW YORK, June 3, 2020 /PRNewswire/ -- USA CBD brand PureKana, one of the global leaders in hemp-based CBD products, has announced the release of its long-awaited line of AM/PM CBD Capsules. The capsules contain proprietary natural sleep and energy blends, and are designed to help improve sleep... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Leading CBD Brand PremiumJane Announces Launch of Jane's Pets; Releases New Line of CBD Oil for Pets

NEW YORK, June 3, 2020 /PRNewswire/ -- PremiumJane, one of the most successful companies in the CBD industry, has just launched Jane's Pets, a brand new line of CBD-based products made specifically for dogs. The products from this exciting new range are designed exclusively for pet use, and are... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

BrainStorm to Participate in BIO Digital 2020

NEW YORK, June 3, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced Dr. Ralph Kern, M.D, President and Chief Medical Officer will present a corporate overview during the BIO International... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  BrainStorm Cell Therapeutics Inc.

American Regent Introduces Estradiol Valerate Injection, USP­; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2

SHIRLEY, N.Y., June 3, 2020 /PRNewswire/ -- American Regent announces the introduction and availability of Estradiol Valerate Injection, USP - AO Rated and therapeutically equivalent to Delestrogen®(1,2).

Read more ››
By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  American Regent, Inc.

Katana Pharmaceuticals Awarded up to $1.05 Million Innovative Challenge Grant from March of Dimes to Support the Development of a Novel Non-Opioid Treatment for Neonatal Abstinence Syndrome

SAN FRANCISCO, June 3, 2020 /PRNewswire/ -- Katana Pharmaceuticals Inc. (Katana), a San Francisco-based startup biotech company developing novel treatments for neonatal patient populations and rare pediatric disorders, today announced the receipt of the first payment of an up to $1.05 million... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

TORONTO, June 3, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  FSD Pharma Inc.

North Bud Farms Provides Corporate Update

Read more ››
By: GlobenewsWire - 03 Jun 2020

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Intellia Therapeutics, Inc.

OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  OraSure Technologies, Inc.

Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels

Read more ››
By: GlobenewsWire - 03 Jun 2020
Related companies:  Hyloris Pharmaceuticals SA

Toni Nesci Named Head of Mayne Contract Services and New Website Launched

ADELAIDE, Australia, June 3, 2020 /PRNewswire/ -- Toni Nesci has been appointed Head of Mayne Contract Services, a division of the Mayne Pharma family. Mayne Contract Services, based in Salisbury, South Australia is the full-service pharmaceutical development and manufacturing business unit created... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  Mayne Pharma International Pty Ltd

Eleva's Drug Candidate to Be Examined for Use in COVID-19 Treatment

FREIBURG, Germany, June 3, 2020 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020

Pliant Therapeutics Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., June 2, 2020 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the pricing of its initial public offering of 9,000,000 shares of... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  Pliant Therapeutics, Inc.

Evofem Announces Pricing of Approximately $100 Million Public Offering of Common Stock

SAN DIEGO, June 2, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, today announced the pricing of an underwritten... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  Evofem Biosciences, Inc.

Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study

SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announces... Read more ››

By: PR Newswire Association LLC. - 03 Jun 2020
Related companies:  Innovent Biologics Co., Ltd.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies